This company listing is no longer active
OVN Stock Overview
Oventus Medical Limited, a medical device company, develops and commercializes oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Oventus Medical Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.02 |
| 52 Week High | AU$0.15 |
| 52 Week Low | AU$0.017 |
| Beta | 0.89 |
| 1 Month Change | 0% |
| 3 Month Change | -9.09% |
| 1 Year Change | -80.00% |
| 3 Year Change | -96.49% |
| 5 Year Change | -94.03% |
| Change since IPO | -97.14% |
Recent News & Updates
Recent updates
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Oventus Medical Limited's (ASX:OVN) CEO For Now
Nov 11
Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?
May 09Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?
Jan 24
Loss-Making Oventus Medical Limited (ASX:OVN) Expected To Breakeven In The Medium-Term
Nov 30Shareholder Returns
| OVN | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 0% | -2.4% | -3.0% |
| 1Y | -80.0% | 12.6% | 3.9% |
Return vs Industry: OVN underperformed the Australian Medical Equipment industry which returned -21.1% over the past year.
Return vs Market: OVN underperformed the Australian Market which returned -9.8% over the past year.
Price Volatility
| OVN volatility | |
|---|---|
| OVN Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 10.3% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.2% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: OVN has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine OVN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | John Cox | o2vent.com |
Oventus Medical Limited, a medical device company, develops and commercializes oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States. The company offers O2Vent Optima, a 3D-printed nylon oral appliance for OSA patients; and ExVent, a valve accessory that fits into the open airway of the O2Vent Optima device. The company was incorporated in 2015 and is headquartered in Indooroopilly, Australia.
Oventus Medical Limited Fundamentals Summary
| OVN fundamental statistics | |
|---|---|
| Market cap | AU$4.83m |
| Earnings (TTM) | -AU$10.29m |
| Revenue (TTM) | AU$1.09m |
4.4x
P/S Ratio-0.5x
P/E RatioIs OVN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OVN income statement (TTM) | |
|---|---|
| Revenue | AU$1.09m |
| Cost of Revenue | AU$654.09k |
| Gross Profit | AU$439.45k |
| Other Expenses | AU$10.73m |
| Earnings | -AU$10.29m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.043 |
| Gross Margin | 40.18% |
| Net Profit Margin | -941.33% |
| Debt/Equity Ratio | 0% |
How did OVN perform over the long term?
See historical performance and comparison